Fig. 3From: Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapyKaplan–Meier survival curves for 2DCRT and IMRTBack to article page